USPTO serial 79386489
ATX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EULIN, INGRID C
- Law office
- TMEG LAW OFFICE 105
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ATX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products; veterinary products; chemical preparations for medical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; all these products being intended for use in the treatment of complex pain | ACTIVE | — |
| 042 | Scientific and technical research services; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; all these services being intended to be offered for the treatment of complex pain | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 6, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 6, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 13, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 6, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 6, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 28, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 28, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |